Cingulate therapeutics ipo
WebSep 10, 2024 · Cingulate Inc filed for an IPO, penciling in a modest $58 million raise, and expects to list on NASDAQ under CING ticker. Cingulate has a Phase 3-ready attention deficit hyperactivity... WebDec 8, 2024 · Use the CB Insights Platform to explore Cingulate Therapeutics's full profile. Cingulate Therapeutics - Products, Competitors, Financials, Employees, Headquarters Locations Technology Vendors
Cingulate therapeutics ipo
Did you know?
WebMar 14, 2024 · With sales of ADHD medication increasing 8 percent each year since 2010, Cingulate could be in a position to capture a significant share of the $18 billion total ADHD prescription drug market. WebCingulate Inc. 1,061 followers. 2mo. Today we announce our Q3 2024 financial results and provided a clinical and business update, including updated study timelines for our lead …
WebOct 8, 2024 · Cognition Therapeutics priced its IPO at the mid-point. Cognition Therapeutics raised $45.2 million by offering 3.8 million shares in the IPO at $12 each. Previously, the company planned to offer ... WebCingulate Therapeutics, LLC (CTx) is a privately held, clinical-stage biopharmaceutical company focused on the development of innovative new products utilizing the Company’s disruptive, proprietary Precision Timed Release™ (PTR™) drug delivery platform technology incorporating a proprietary Erosion Barrier Layer (EBL) enabling the creation of true once …
WebCING Complete Cingulate Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. WebSee the newest and upcoming IPOs (Initial Public Offerings) announcements and details. Quarterly Earnings Calendar Learn when companies will announce their quarterly …
WebCingulate upsized its IPO at pricing on Dec. 7, 2024, to 4.17 million shares, up from 3.57 ...
WebCingulate Inc is a clinical stage biopharmaceutical company utilizing its proprietary precision timed release drug delivery platform to build and advance a pipeline of next-generation … isb teamWebOct 12, 2024 · Three healthcare IPOs are set for pricing Thursday night, Oct. 14, to start trading on Friday the 15 th: Cingulate Inc. (CING proposed), a clinical biopharma deal … is btd6 on steamWebApr 10, 2024 · Analyst Forecast. According to 10 analysts, the average rating for CING stock is "Buy." The 12-month stock price forecast is $5.99, which is an increase of 508.12% … is btd battles 2 freeWeb1y Target Est. 5.88. Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return ... is btd battles 2 goodWebDec 8, 2024 · Cingulate Inc. is a clinical-stage biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to … is btec an a levelWebFounded Date Dec 1, 2012. Founders Craig Gilgallon, Matthew Brams, Raul Silva, Shane J Schaffer. Operating Status Active. Last Funding Type Venture - Series Unknown. Stock Symbol NASDAQ:CING. Company … is btech better than bscWebSep 30, 2024 · Cingulate (NASDAQ: CING ), the biotech company that is developing formulations of stimulant drugs for ADHD, is making its public debut soon. Here are 7 key things to know about the upcoming CING... is btec equivalent to 3 a levels